Indication

For treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older

Medicine details

Medicine name:
odevixibat (Bylvay)
SMC ID:
SMC2411
Pharmaceutical company
Albireo Pharma
BNF chapter
Gastro-intestinal system
Submission type
Ultra-orphan initial assessment
Publication due date:
11 July 2022
SMC meeting date:
01 March 2022
Patient group submission deadline:
13 December 2021